Raman imaging studies on the stability of Paracetamol tablets under different storage conditions

abstract

The applicability of Raman imaging for pharmaceutics production ranges from the characterization of phar-maceutical formulations, kinetic processes in drug delivery to the rapid detection and identification of coun-terfeit drugs/contaminants. Acetaminophen (Paracetamol, APAP) is an analgesic and antipyretic drug and one of the most consumed medicines worldwide. On the other hand, the compound 4-aminophenol (4-AP) is a hy-drolytic product of APAP with nephrotoxicity and teratogenic effects. In this work, we have explored for the first time Raman imaging methods to characterize the main components of commercial APAP tablets (APAP-tablets) and to inquire about the potential of this optical technique to identify 4-AP in APAP tablets, which have been previously spiked with such contaminant. The laboratorial treated APAP-tablet samples were subjected to different temperature, humidity and sunlight exposure conditions, mimicking storage conditions, and then the Raman spectra and images were collected to monitor changes that might occur in those conditions. Although the lower limit of detection of 4-AP in APAP-tablets is above the minimum levels established by Pharmacopoeias (0.005 %), this research demonstrates that Raman imaging still allows the detection of small amounts of the contaminant, thus opening perspectives for exploring this technique for characterizing APAP products.

keywords

ACETYL-P-AMINOPHENOL; SPECTROPHOTOMETRIC DETERMINATION; PHARMACEUTICAL FORMULATIONS; RAPID ASSAY; SPECTROSCOPY; QUALITY; ACETAMINOPHEN; DEGRADATION; SURFACE; DRUG

subject category

Chemistry; Spectroscopy

authors

Fateixa, S; Mulandeza, O; Nogueira, HIS; Trindade, T

our authors

acknowledgements

This work was developed within the scope of the project CICECO-Aveiro Institute of Materials, UIDB/50011/2020, UIDP/50011/2020 & LA/P/0006/2020, financed by national funds through the FCT/MCTES (PIDDAC) and when appropriate cofinanced by FEDER under the PT2020 Partnership Agreement. S. F. thanks FCT for her research contract (REF-069-88-ARH-2018), which is funded by national funds (OE), through FCT-Fundacao para a Ciencia e a Tecnologia, I.P., in the scope of the framework contract foreseen in the numbers 4, 5, and 6 of the article 23, of the Decree-Law 57/2016, of August 29, changed by Law 57/2017, of July 19.

Share this project:

Related Publications

We use cookies for marketing activities and to offer you a better experience. By clicking “Accept Cookies” you agree with our cookie policy. Read about how we use cookies by clicking "Privacy and Cookie Policy".